You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prostaglandin D2 receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

Enrolling by invitation
  • Dopamine D2/3 Receptor Availability
  • +2 more
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • PET scans
  • (no location specified)
Nov 9, 2022

Metabolism of Prostaglandin D2 Trial in Nashville (dietary supplement, drug, other)

Enrolling by invitation
  • Metabolism of Prostaglandin D2
  • niacin
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University
Jan 25, 2022

Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

Not yet recruiting
  • Advanced Sarcoma
  • NKG2D-CAR memory T cell
  • (no location specified)
Oct 17, 2023

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Amyotrophic Lateral Sclerosis Trial in St. Gallen ([18F]-RoSMA-18-d6)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • St. Gallen, Switzerland
    Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen
May 19, 2023

Advanced Solid Tumors Trial in Hangzhou (Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT))

Recruiting
  • Advanced Solid Tumors
  • Universal Chimeric Natural Killer Receptor Modified T-cells (CNK-UT)
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Aug 3, 2023

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Diabetic Macular Edema, Diabetic Retinopathy Trial in Querétaro City, Queretaro (DME lactose pill, DME levosulpiride, DR lactose

Recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • DME lactose pill
  • +7 more
  • Querétaro City, Queretaro, Mexico
  • +1 more
Oct 31, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Advanced Solid Tumor Trial in Shanghai (IMC008)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Apr 19, 2023

SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul

Completed
  • SARS CoV 2 Infection
  • +3 more
    • Istanbul, Turkey
      Haseki Training and Research Hospital
    Nov 17, 2022

    Type 1 Diabetes Trial in La Jolla (Dapagliflozin 10 MG [Farxiga], REMD-477, Placebo)

    Completed
    • Type 1 Diabetes
    • Dapagliflozin 10 MG [Farxiga]
    • +2 more
    • La Jolla, California
      UC San Diego Altman Clinical & Translational Research Institute
    Jan 20, 2023

    Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T

    Not yet recruiting
    • Cancer
    • +3 more
    • Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
    • Singapore, Singapore
      National University Hospital
    Mar 20, 2022

    Prostaglandin and Cannabinoid Receptors in EoE

    Recruiting
    • Eosinophilic Esophagitis (EoE)
    • Biopsy samples
    • Blood samples
    • Graz, Austria
      Medical University of Graz
    Aug 31, 2021

    Atopic Asthma Trial in Hannover (Blood Sampling)

    Completed
    • Atopic Asthma
    • Blood Sampling
    • Hannover, Niedersachsen, Germany
      Fraunhofer ITEM im CRC
    Jun 16, 2020

    Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

    Recruiting
    • Early-stage Breast Cancer
    • +6 more
    • Fullerton, California
    • +8 more
    Sep 19, 2022

    Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

    Recruiting
    • Advanced Breast Carcinoma
    • +17 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)

    Not yet recruiting
    • NMDAR Autoimmune Encephalitis
    • LGI1 Autoimmune Encephalitis
    • Prague, Czechia
    • +1 more
    Aug 15, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Bintrafusp Alfa
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 2, 2022

    Empagliflozin in Type 2 Diabetes Population With and Without

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Durham, North Carolina
      Duke Clinical Research Institute
    Aug 8, 2022

    Breast Cancer Trial in Barcelona, Lleida, Tarragona (Onapristone)

    Completed
    • Breast Cancer
    • Barcelona, Spain
    • +3 more
    Mar 31, 2022